Answers are grounded in this paper and cite their sources.
Background: Oral phosphodiesterase type 5 (PDE5) inhibitors are established first-line pharmacotherapies for erectile dysfunction (ED), yet approximately 30% to 35% of patients fail to achieve satisfactory rigidity. Objective: To review the physiological rationale, clinical efficacy evidence, and safety profile of external penile constriction devices (PCDs)—applied alone or banded with vacuum erection therapy—as mechanical adjuncts to salvage PDE5 inhibitor non-responders, and to propose a structured clinical escalation protocol. Results: Combination therapy leverages complementary physiological mechanisms: PDE5 inhibitors amplify NO-mediated cavernosal smooth muscle relaxation, whereas external constriction rings restrict venous drainage through Buck's fascia. Conclusions: External penile constriction devices represent an underutilized, non-invasive, low-cost salvage modality prior to initiating invasive therapies. Conflict of Interest: Dr. Mohd Amiruddin Mohd Nor is the clinical founder and medical director of SuamiSihat Clinic and has commercial involvement with the Dr MIT Ring constriction device.
No takes yet. Share an insight, caveat, or question.
Mohd Amiruddin Mohd Nor (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: